Aerobic Exercise for Remyelination in Multiple Sclerosis

NCT04539002 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-07-31

No results posted yet for this study

Summary

This is a clinical trial to determine the feasibility of a stationary aerobic cycling intervention and explore if aerobic exercise independently promotes remyelination in people with multiple sclerosis (MS).

Conditions

  • Multiple Sclerosis
  • Sclerosis
  • Demyelinating Diseases
  • Autoimmune Diseases of the Nervous System
  • Nervous System Diseases
  • Demyelinating Autoimmune Diseases, CNS
  • Exercise

Interventions

BEHAVIORAL

Aerobic exercise

Aerobic exercise performed on a stationary ergometer for 30 minutes, thrice weekly, with graded supervision. Participants will participate in the intervention over 24 weeks.

BEHAVIORAL

Education Group Control

A monthly, hour-long, class over various MS topics and symptoms, led by a trained facilitator.

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • Portland VA Medical Center

    collaborator FED
  • Oregon Clinical and Translational Research Institute

    collaborator OTHER
  • Myelin Repair Foundation

    collaborator UNKNOWN
  • EMD Serono

    collaborator INDUSTRY
  • Medical Research Foundation, Oregon

    collaborator OTHER
  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Lindsey B Wooliscroft, MD · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-29
Primary Completion
2025-03-27
Completion
2025-03-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04539002 on ClinicalTrials.gov